Evidence map›Paper›PMID 39190474›Full record

ArticleFuture medicinal chemistry2024

Ibrahim Mohey El-Deen, Elsayed H Eltamany, Nourhan M Ali

Abstract read
In one paragraph

Article in Future medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Future medicinal chemistry · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ibrahim Mohey El-DeenDepartment of Chemistry (The Division of Organic Chemistry), Faculty of Science, Port Said University, Port Said, Egypt.ORCID 0000-0003-3793-6235
Elsayed H EltamanyDepartment of Chemistry, Faculty of Science, Suez Canal University, Ismailia, Egypt.ORCID 0000-0002-9210-1647
Nourhan M AliDepartment of Chemistry, Faculty of Science, Suez Canal University, Ismailia, Egypt.ORCID 0009-0002-0270-686X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic AgentsApoptosisDrug Screening Assays, AntitumorThionesCell Line, TumorCell ProliferationDose-Response Relationship, DrugHCT116 CellsHep G2 CellsHumansImidazolidinesMolecular StructureNF-E2-Related Factor 2Structure-Activity RelationshipAntineoplastic AgentsImidazolidinesNF-E2-Related Factor 2Thiones2-thioxoimidazolidine derivativesantiproliferationcell cycle arrestcolon cancerliver cancerNF-E2-related factorNrf2quantitative real time PCR

Identifiers

PMID39190474
PMCPMC11352705

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.